Your browser doesn't support javascript.
loading
Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018-2022.
Wise, Mark G; Karlowsky, James A; Mohamed, Naglaa; Hermsen, Elizabeth D; Kamat, Shweta; Townsend, Andy; Brink, Adrian; Soriano, Alex; Paterson, David L; Moore, Luke S P; Sahm, Daniel F.
Afiliación
  • Wise MG; IHMA, Schaumburg, IL. Electronic address: mwise@ihma.com.
  • Karlowsky JA; IHMA, Schaumburg, IL; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Mohamed N; Pfizer Inc., New York, NY.
  • Hermsen ED; Pfizer Inc., New York, NY.
  • Kamat S; Pfizer Ltd, Mumbai, India.
  • Townsend A; Pfizer Hospital Medical Affairs, Pfizer, Congleton, UK.
  • Brink A; Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; National Health Laboratory Service, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, Faculty of Health Scie
  • Soriano A; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Paterson DL; ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore; Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Moore LSP; Clinical Infection Department, Chelsea and Westminster NHS Foundation Trust, London, UK; Imperial College Healthcare NHS Trust, North West London Pathology, London, UK; NIHR Health Protection Research Unit in Healthcare Associated Infections & Antimicrobial Resistance, Imperial College London, L
  • Sahm DF; IHMA, Schaumburg, IL.
J Glob Antimicrob Resist ; 37: 168-175, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38608936
ABSTRACT

OBJECTIVES:

To report trends in carbapenem resistance and difficult-to-treat resistance (DTR) among clinical isolates of Gram-negative priority pathogens collected by the ATLAS global surveillance program from 2018 to 2022.

METHODS:

Reference broth microdilution testing was performed in a central laboratory for 79,214 Enterobacterales, 30,504 Pseudomonas aeruginosa, and 13,500 Acinetobacter baumannii-calcoaceticus complex isolates collected by a constant set of 157 medical centres in 49 countries in Asia Pacific (APAC), Europe (EUR), Latin America (LATAM), Middle East-Africa (MEA), and North America (NA) regions. MICs were interpreted by 2023 CLSI M100 breakpoints. ß-lactamase genes were identified for meropenem-nonsusceptible (MIC ≥2 mg/L) Enterobacterales isolates.

RESULTS:

Carbapenem-resistant Enterobacterales (CRE) detection increased (P < 0.05) in APAC, EUR, LATAM, and MEA regions and decreased in NA, while annual DTR percentages increased in all five regions. Carbapenem-resistant P. aeruginosa (CRPA; decreased in MEA region) and carbapenem-resistant A. baumannii-calcoaceticus complex (CRAB; decreased in MEA region and increased in EUR) remained relatively stable over time in all regions, although notably, annual percentages of CRAB and DTR A. baumannii-calcoaceticus complex isolates were consistently >25 percentage points lower in NA than in other regions. For all regions except NA, the majority of changes in CRE percentages could be attributed to hospital-acquired infections. Among meropenem-nonsusceptible Enterobacterales, KPC was the most frequent carbapenemase in NA and EUR each year. NDM was the most prevalent carbapenemase detected in 2022 in other global regions.

CONCLUSION:

CRE, CRPA, CRAB, and DTR rates vary among global regions over time highlighting the need for continuing surveillance to inform treatment strategies and antimicrobial stewardship.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pruebas de Sensibilidad Microbiana / Carbapenémicos / Antibacterianos Límite: Humans Idioma: En Revista: J Glob Antimicrob Resist Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pruebas de Sensibilidad Microbiana / Carbapenémicos / Antibacterianos Límite: Humans Idioma: En Revista: J Glob Antimicrob Resist Año: 2024 Tipo del documento: Article